Clover Health Investments, Corp. - Class A Common stock (CLOV) earnings

CLOV earnings moved a median of -0.68% by the close. Quarterly and annual CLOV reports and results, each read against the price at its own news timestamp. Back to the CLOV overview →

30 measured CLOV earnings events.

Where these CLOV earnings landedvs 30 measured CLOV earnings reactions
CLOV earningsMiddle 50% · -4.38% to +2.10%Zero: 0.00%Median: -0.68%Median -0.68%-6.00%0+6.00%
Middle 50% of CLOV earnings reactions-4.38% to +2.10%
Median reaction (to close)-0.68%
Measured reactions30
Point-in-time · zero look-ahead

Half of the 30 CLOV earnings events with a measured close landed between -4.38% and +2.10%; 43% closed up.

DateHeadlineEvent5-minTo close
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026Press release+0.22%+1.78%
Form 10-Q CLOVER HEALTH INVESTMENT For: Jun 30SEC filing · Form 10-Q+0.42%+0.85%
Clover Health Reports Second Quarter 2026 ResultsPress release+1.13%-4.70%
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026Press release-2.25%-4.92%
Form 10-Q CLOVER HEALTH INVESTMENT For: Mar 31SEC filing · Form 10-Q+1.06%+10.64%
Clover Health Reports First Quarter 2026 ResultsPress release-0.54%+2.17%
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026Press release+1.32%+0.53%
Form 10-K CLOVER HEALTH INVESTMENT For: Dec 31SEC filing · Form 10-K+0.19%+1.46%
Form 10-Q CLOVER HEALTH INVESTMENT For: Sep 30SEC filing · Form 10-Q-1.54%+3.09%
Clover Health Reports Third Quarter 2025 ResultsPress release+0.53%+5.14%
Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025Press release+3.02%+1.89%
Form 10-Q CLOVER HEALTH INVESTMENT For: Jun 30SEC filing · Form 10-Q-1.13%-1.36%
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable GrowthPress release+1.29%-3.00%
Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025Press release+7.05%+0.00%
Form 10-Q CLOVER HEALTH INVESTMENT For: Mar 31SEC filing · Form 10-Q-1.59%-6.90%
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 GuidancePress release+4.12%+10.88%
Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025Press release+0.00%+6.45%
Form 10-K CLOVER HEALTH INVESTMENT For: Dec 31SEC filing · Form 10-K+0.00%-6.67%
Form 10-Q CLOVER HEALTH INVESTMENT For: Sep 30SEC filing · Form 10-Q-1.22%-7.59%
Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow MembershipPress release-1.80%-5.66%
Clover Health to Report Third Quarter 2024 Financial Results on November 6Press release+2.38%+0.00%
Form 10-Q CLOVER HEALTH INVESTMENT For: Jun 30SEC filing · Form 10-Q+3.29%+9.58%
Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong PerformancePress release-4.95%-8.50%
Clover Health to Report Second Quarter 2024 Financial Results on August 5Press release+0.30%-1.77%
Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA ProfitabilityPress release-2.61%-1.52%
Form 10-Q CLOVER HEALTH INVESTMENT For: Mar 31SEC filing · Form 10-Q-2.61%-1.52%
Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024Press release+0.77%+3.59%
Form 10-K CLOVER HEALTH INVESTMENT For: Dec 31SEC filing · Form 10-K-2.37%-11.59%
Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 GuidancePress release+1.90%-3.41%
Form 10-Q CLOVER HEALTH INVESTMENT For: Sep 30SEC filing · Form 10-Q+1.90%-3.41%
That’s how CLOV usually reacts to earnings — get an email when it moves on news →
Keep exploring

More CLOV: analyst actions → · SEC filings → · CLOV overview →